Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Publications

Search Items: LUNG NEOPLASMS - BLOOD , . hits: 10

2017

Dandachi, N; Tiran, V; Lindenmann, J; Brcic, L; Fink-Neuboeck, N; Kashofer, K; Absenger, G; Bezan, A; Cote, RJ; Datar, R; Balic, M Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Lung Cancer. 2017; 113(46):152-157
Web of Science PubMed FullText FullText_MUG

 

Joshi, PK; Pirastu, N; Kentistou, KA; Fischer, K; Hofer, E; Schraut, KE; Clark, DW; Nutile, T; Barnes, CLK; Timmers, PRHJ; Shen, X; Gandin, I; McDaid, AF; Hansen, TF; Gordon, SD; Giulianini, F; Boutin, TS; Abdellaoui, A; Zhao, W; Medina-Gomez, C; Bartz, TM; Trompet, S; Lange, LA; Raffield, L; van der Spek, A; Galesloot, TE; Proitsi, P; Yanek, LR; Bielak, LF; Payton, A; Murgia, F; Concas, MP; Biino, G; Tajuddin, SM; Seppälä, I; Amin, N; Boerwinkle, E; Børglum, AD; Campbell, A; Demerath, EW; Demuth, I; Faul, JD; Ford, I; Gialluisi, A; Gögele, M; Graff, M; Hingorani, A; Hottenga, JJ; Hougaard, DM; Hurme, MA; Ikram, MA; Jylhä, M; Kuh, D; Ligthart, L; Lill, CM; Lindenberger, U; Lumley, T; Mägi, R; Marques-Vidal, P; Medland, SE; Milani, L; Nagy, R; Ollier, WER; Peyser, PA; Pramstaller, PP; Ridker, PM; Rivadeneira, F; Ruggiero, D; Saba, Y; Schmidt, R; Schmidt, H; Slagboom, PE; Smith, BH; Smith, JA; Sotoodehnia, N; Steinhagen-Thiessen, E; van Rooij, FJA; Verbeek, AL; Vermeulen, SH; Vollenweider, P; Wang, Y; Werge, T; Whitfield, JB; Zonderman, AB; Lehtimäki, T; Evans, MK; Pirastu, M; Fuchsberger, C; Bertram, L; Pendleton, N; Kardia, SLR; Ciullo, M; Becker, DM; Wong, A; Psaty, BM; van Duijn, CM; Wilson, JG; Jukema, JW; Kiemeney, L; Uitterlinden, AG; Franceschini, N; North, KE; Weir, DR; Metspalu, A; Boomsma, DI; Hayward, C; Chasman, D; Martin, NG; Sattar, N; Campbell, H; Esko, T; Kutalik, Z; Wilson, JF Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity.
Nat Commun. 2017; 8(1):910-910 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Su, Y; Hu, Y; Wang, Y; Xu, X; Yuan, Y; Li, Y; Wang, Z; Chen, K; Zhang, F; Ding, X; Li, M; Zhou, J; Liu, Y; Wang, W A precision-guided MWNT mediated reawakening the sunk synergy in RAS for anti-angiogenesis lung cancer therapy.
Biomaterials. 2017; 139(28): 75-90.
Web of Science PubMed FullText FullText_MUG

 

2016

Bohlsen, D; Talakic, E; Fritz, GA; Quehenberger, F; Tillich, M; Schoellnast, H First pass dual input volume CT-perfusion of lung lesions: The influence of the CT- value range settings on the perfusion values of benign and malignant entities.
Eur J Radiol. 2016; 85(6):1109-1114
Web of Science PubMed FullText FullText_MUG

 

Hoda, MA; Dong, Y; Rozsas, A; Klikovits, T; Laszlo, V; Ghanim, B; Stockhammer, P; Ozsvar, J; Jakopovic, M; Samarzija, M; Brcic, L; Bendek, M; Szirtes, I; Reid, G; Kirschner, MB; Kao, SC; Opitz, I; Weder, W; Frauenfelder, T; Nguyen-Kim, TD; Aigner, C; Klepetko, W; van Zandwijk, N; Berger, W; Dome, B; Grusch, M; Hegedus, B Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Eur J Cancer. 2016; 63(1):64-73 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Ghanim, B; Hoda, MA; Klikovits, T; Winter, MP; Alimohammadi, A; Grusch, M; Dome, B; Arns, M; Schenk, P; Jakopovic, M; Samarzija, M; Brcic, L; Filipits, M; Laszlo, V; Klepetko, W; Berger, W; Hegedus, B Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.
Br J Cancer. 2014; 110(4): 984-990. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Posch, F; Setinek, U; Flores, RM; Bernhard, D; Hannigan, GE; Mueller, MR; Watzka, SB Serum integrin-linked kinase (sILK) concentration and survival in non-small cell lung cancer: a pilot study.
Clin Transl Oncol. 2014; 16(5): 455-462.
Web of Science PubMed FullText FullText_MUG

 

2003

Sasaki, H; Yu, CY; Dai, M; Tam, C; Loda, M; Auclair, D; Chen, LB; Elias, A Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.
Breast Cancer Res Treat. 2003; 77(3): 245-252.
Web of Science PubMed FullText FullText_MUG

 

2002

Vejda, S; Posovszky, C; Zelzer, S; Peter, B; Bayer, E; Gelbmann, D; Schulte-Hermann, R; Gerner, C Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis.
MOL CELL PROTEOMICS. 2002; 1: 387-393. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1984

Starczewski, M; Voigtmann, R; Peskar, BA; Peskar, BM Plasma levels of 15-keto-13,14-dihydro-prostaglandin E2 in patients with bronchogenic carcinoma.
Prostaglandins Leukot Med. 1984; 13(3):249-258
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni GrazImprint